Summary
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
According to APO Research, The global Mebendazole market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Mebendazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Mebendazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Mebendazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Mebendazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Mebendazole include Johnson & Johnson, Amneal Pharmaceuticals, Cadila Pharmaceuticals, Eipico, Esteve Pharmaceuticals and Tenry, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Mebendazole, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Mebendazole, also provides the sales of main regions and countries. Of the upcoming market potential for Mebendazole, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mebendazole sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Mebendazole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Mebendazole sales, projected growth trends, production technology, application and end-user industry.
Mebendazole segment by Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Mebendazole segment by Type
Tablet
Oral Suspension
Mebendazole segment by Application
Below 2 Years Old
Above 2 Years Old
Mebendazole segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mebendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebendazole.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Mebendazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Mebendazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mebendazole sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Mebendazole Market by Type
1.2.1 Global Mebendazole Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Tablet
1.2.3 Oral Suspension
1.3 Mebendazole Market by Application
1.3.1 Global Mebendazole Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Below 2 Years Old
1.3.3 Above 2 Years Old
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Mebendazole Market Dynamics
2.1 Mebendazole Industry Trends
2.2 Mebendazole Industry Drivers
2.3 Mebendazole Industry Opportunities and Challenges
2.4 Mebendazole Industry Restraints
3 Global Market Growth Prospects
3.1 Global Mebendazole Revenue Estimates and Forecasts (2019-2030)
3.2 Global Mebendazole Revenue by Region
3.2.1 Global Mebendazole Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Mebendazole Revenue by Region (2019-2024)
3.2.3 Global Mebendazole Revenue by Region (2025-2030)
3.2.4 Global Mebendazole Revenue Market Share by Region (2019-2030)
3.3 Global Mebendazole Sales Estimates and Forecasts 2019-2030
3.4 Global Mebendazole Sales by Region
3.4.1 Global Mebendazole Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Mebendazole Sales by Region (2019-2024)
3.4.3 Global Mebendazole Sales by Region (2025-2030)
3.4.4 Global Mebendazole Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Mebendazole Revenue by Manufacturers
4.1.1 Global Mebendazole Revenue by Manufacturers (2019-2024)
4.1.2 Global Mebendazole Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Mebendazole Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Mebendazole Sales by Manufacturers
4.2.1 Global Mebendazole Sales by Manufacturers (2019-2024)
4.2.2 Global Mebendazole Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Mebendazole Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Mebendazole Sales Price by Manufacturers (2019-2024)
4.4 Global Mebendazole Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Mebendazole Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Mebendazole Manufacturers, Product Type & Application
4.7 Global Mebendazole Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Mebendazole Market CR5 and HHI
4.8.2 2023 Mebendazole Tier 1, Tier 2, and Tier 3
5 Mebendazole Market by Type
5.1 Global Mebendazole Revenue by Type
5.1.1 Global Mebendazole Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Mebendazole Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Mebendazole Revenue Market Share by Type (2019-2030)
5.2 Global Mebendazole Sales by Type
5.2.1 Global Mebendazole Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Mebendazole Sales by Type (2019-2030) & (K Units)
5.2.3 Global Mebendazole Sales Market Share by Type (2019-2030)
5.3 Global Mebendazole Price by Type
6 Mebendazole Market by Application
6.1 Global Mebendazole Revenue by Application
6.1.1 Global Mebendazole Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Mebendazole Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Mebendazole Revenue Market Share by Application (2019-2030)
6.2 Global Mebendazole Sales by Application
6.2.1 Global Mebendazole Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Mebendazole Sales by Application (2019-2030) & (K Units)
6.2.3 Global Mebendazole Sales Market Share by Application (2019-2030)
6.3 Global Mebendazole Price by Application
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Comapny Information
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Mebendazole Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Johnson & Johnson Mebendazole Product Portfolio
7.1.5 Johnson & Johnson Recent Developments
7.2 Amneal Pharmaceuticals
7.2.1 Amneal Pharmaceuticals Comapny Information
7.2.2 Amneal Pharmaceuticals Business Overview
7.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Amneal Pharmaceuticals Mebendazole Product Portfolio
7.2.5 Amneal Pharmaceuticals Recent Developments
7.3 Cadila Pharmaceuticals
7.3.1 Cadila Pharmaceuticals Comapny Information
7.3.2 Cadila Pharmaceuticals Business Overview
7.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Cadila Pharmaceuticals Mebendazole Product Portfolio
7.3.5 Cadila Pharmaceuticals Recent Developments
7.4 Eipico
7.4.1 Eipico Comapny Information
7.4.2 Eipico Business Overview
7.4.3 Eipico Mebendazole Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Eipico Mebendazole Product Portfolio
7.4.5 Eipico Recent Developments
7.5 Esteve Pharmaceuticals
7.5.1 Esteve Pharmaceuticals Comapny Information
7.5.2 Esteve Pharmaceuticals Business Overview
7.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Esteve Pharmaceuticals Mebendazole Product Portfolio
7.5.5 Esteve Pharmaceuticals Recent Developments
7.6 Tenry
7.6.1 Tenry Comapny Information
7.6.2 Tenry Business Overview
7.6.3 Tenry Mebendazole Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Tenry Mebendazole Product Portfolio
7.6.5 Tenry Recent Developments
8 North America
8.1 North America Mebendazole Market Size by Type
8.1.1 North America Mebendazole Revenue by Type (2019-2030)
8.1.2 North America Mebendazole Sales by Type (2019-2030)
8.1.3 North America Mebendazole Price by Type (2019-2030)
8.2 North America Mebendazole Market Size by Application
8.2.1 North America Mebendazole Revenue by Application (2019-2030)
8.2.2 North America Mebendazole Sales by Application (2019-2030)
8.2.3 North America Mebendazole Price by Application (2019-2030)
8.3 North America Mebendazole Market Size by Country
8.3.1 North America Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Mebendazole Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Mebendazole Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Mebendazole Market Size by Type
9.1.1 Europe Mebendazole Revenue by Type (2019-2030)
9.1.2 Europe Mebendazole Sales by Type (2019-2030)
9.1.3 Europe Mebendazole Price by Type (2019-2030)
9.2 Europe Mebendazole Market Size by Application
9.2.1 Europe Mebendazole Revenue by Application (2019-2030)
9.2.2 Europe Mebendazole Sales by Application (2019-2030)
9.2.3 Europe Mebendazole Price by Application (2019-2030)
9.3 Europe Mebendazole Market Size by Country
9.3.1 Europe Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Mebendazole Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Mebendazole Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Mebendazole Market Size by Type
10.1.1 China Mebendazole Revenue by Type (2019-2030)
10.1.2 China Mebendazole Sales by Type (2019-2030)
10.1.3 China Mebendazole Price by Type (2019-2030)
10.2 China Mebendazole Market Size by Application
10.2.1 China Mebendazole Revenue by Application (2019-2030)
10.2.2 China Mebendazole Sales by Application (2019-2030)
10.2.3 China Mebendazole Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Mebendazole Market Size by Type
11.1.1 Asia Mebendazole Revenue by Type (2019-2030)
11.1.2 Asia Mebendazole Sales by Type (2019-2030)
11.1.3 Asia Mebendazole Price by Type (2019-2030)
11.2 Asia Mebendazole Market Size by Application
11.2.1 Asia Mebendazole Revenue by Application (2019-2030)
11.2.2 Asia Mebendazole Sales by Application (2019-2030)
11.2.3 Asia Mebendazole Price by Application (2019-2030)
11.3 Asia Mebendazole Market Size by Country
11.3.1 Asia Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Mebendazole Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Mebendazole Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Mebendazole Market Size by Type
12.1.1 MEALA Mebendazole Revenue by Type (2019-2030)
12.1.2 MEALA Mebendazole Sales by Type (2019-2030)
12.1.3 MEALA Mebendazole Price by Type (2019-2030)
12.2 MEALA Mebendazole Market Size by Application
12.2.1 MEALA Mebendazole Revenue by Application (2019-2030)
12.2.2 MEALA Mebendazole Sales by Application (2019-2030)
12.2.3 MEALA Mebendazole Price by Application (2019-2030)
12.3 MEALA Mebendazole Market Size by Country
12.3.1 MEALA Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Mebendazole Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Mebendazole Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Mebendazole Value Chain Analysis
13.1.1 Mebendazole Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Mebendazole Production Mode & Process
13.2 Mebendazole Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Mebendazole Distributors
13.2.3 Mebendazole Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Mebendazole Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Tablet Major Manufacturers
Table 3. Oral Suspension Major Manufacturers
Table 4. Global Mebendazole Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Below 2 Years Old Major Manufacturers
Table 6. Above 2 Years Old Major Manufacturers
Table 7. Mebendazole Industry Trends
Table 8. Mebendazole Industry Drivers
Table 9. Mebendazole Industry Opportunities and Challenges
Table 10. Mebendazole Industry Restraints
Table 11. Global Mebendazole Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Mebendazole Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Mebendazole Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Mebendazole Revenue Market Share by Region (2019-2024)
Table 15. Global Mebendazole Revenue Market Share by Region (2025-2030)
Table 16. Global Mebendazole Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 17. Global Mebendazole Sales by Region (2019-2024) & (K Units)
Table 18. Global Mebendazole Sales by Region (2025-2030) & (K Units)
Table 19. Global Mebendazole Sales Market Share by Region (2019-2024)
Table 20. Global Mebendazole Sales Market Share by Region (2025-2030)
Table 21. Global Mebendazole Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Mebendazole Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Mebendazole Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Mebendazole Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Mebendazole Sales Price (USD/Unit) of Manufacturers (2019-2024)
Table 26. Global Mebendazole Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Mebendazole Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Mebendazole Manufacturers, Product Type & Application
Table 29. Global Mebendazole Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Mebendazole by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Mebendazole Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Mebendazole Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Mebendazole Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Mebendazole Revenue Market Share by Type (2019-2024)
Table 36. Global Mebendazole Revenue Market Share by Type (2025-2030)
Table 37. Global Mebendazole Sales by Type 2019 VS 2023 VS 2030 (K Units)
Table 38. Global Mebendazole Sales by Type (2019-2024) & (K Units)
Table 39. Global Mebendazole Sales by Type (2025-2030) & (K Units)
Table 40. Global Mebendazole Sales Market Share by Type (2019-2024)
Table 41. Global Mebendazole Sales Market Share by Type (2025-2030)
Table 42. Global Mebendazole Price by Type (2019-2024) & (USD/Unit)
Table 43. Global Mebendazole Price by Type (2025-2030) & (USD/Unit)
Table 44. Global Mebendazole Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Mebendazole Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Mebendazole Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Mebendazole Revenue Market Share by Application (2019-2024)
Table 48. Global Mebendazole Revenue Market Share by Application (2025-2030)
Table 49. Global Mebendazole Sales by Application 2019 VS 2023 VS 2030 (K Units)
Table 50. Global Mebendazole Sales by Application (2019-2024) & (K Units)
Table 51. Global Mebendazole Sales by Application (2025-2030) & (K Units)
Table 52. Global Mebendazole Sales Market Share by Application (2019-2024)
Table 53. Global Mebendazole Sales Market Share by Application (2025-2030)
Table 54. Global Mebendazole Price by Application (2019-2024) & (USD/Unit)
Table 55. Global Mebendazole Price by Application (2025-2030) & (USD/Unit)
Table 56. Johnson & Johnson Company Information
Table 57. Johnson & Johnson Business Overview
Table 58. Johnson & Johnson Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 59. Johnson & Johnson Mebendazole Product Portfolio
Table 60. Johnson & Johnson Recent Development
Table 61. Amneal Pharmaceuticals Company Information
Table 62. Amneal Pharmaceuticals Business Overview
Table 63. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Amneal Pharmaceuticals Mebendazole Product Portfolio
Table 65. Amneal Pharmaceuticals Recent Development
Table 66. Cadila Pharmaceuticals Company Information
Table 67. Cadila Pharmaceuticals Business Overview
Table 68. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cadila Pharmaceuticals Mebendazole Product Portfolio
Table 70. Cadila Pharmaceuticals Recent Development
Table 71. Eipico Company Information
Table 72. Eipico Business Overview
Table 73. Eipico Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Eipico Mebendazole Product Portfolio
Table 75. Eipico Recent Development
Table 76. Esteve Pharmaceuticals Company Information
Table 77. Esteve Pharmaceuticals Business Overview
Table 78. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Esteve Pharmaceuticals Mebendazole Product Portfolio
Table 80. Esteve Pharmaceuticals Recent Development
Table 81. Tenry Company Information
Table 82. Tenry Business Overview
Table 83. Tenry Mebendazole Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Tenry Mebendazole Product Portfolio
Table 85. Tenry Recent Development
Table 86. North America Mebendazole Revenue by Type (2019-2024) & (US$ Million)
Table 87. North America Mebendazole Revenue by Type (2025-2030) & (US$ Million)
Table 88. North America Mebendazole Sales by Type (2019-2024) & (K Units)
Table 89. North America Mebendazole Sales by Type (2025-2030) & (K Units)
Table 90. North America Mebendazole Sales Price by Type (2019-2024) & (USD/Unit)
Table 91. North America Mebendazole Sales Price by Type (2025-2030) & (USD/Unit)
Table 92. North America Mebendazole Revenue by Application (2019-2024) & (US$ Million)
Table 93. North America Mebendazole Revenue by Application (2025-2030) & (US$ Million)
Table 94. North America Mebendazole Sales by Application (2019-2024) & (K Units)
Table 95. North America Mebendazole Sales by Application (2025-2030) & (K Units)
Table 96. North America Mebendazole Sales Price by Application (2019-2024) & (USD/Unit)
Table 97. North America Mebendazole Sales Price by Application (2025-2030) & (USD/Unit)
Table 98. North America Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 99. North America Mebendazole Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 100. North America Mebendazole Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 101. North America Mebendazole Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 102. North America Mebendazole Sales by Country (2019-2024) & (K Units)
Table 103. North America Mebendazole Sales by Country (2025-2030) & (K Units)
Table 104. North America Mebendazole Sales Price by Country (2019-2024) & (USD/Unit)
Table 105. North America Mebendazole Sales Price by Country (2025-2030) & (USD/Unit)
Table 106. US Mebendazole Revenue (2019-2030) & (US$ Million)
Table 107. Canada Mebendazole Revenue (2019-2030) & (US$ Million)
Table 108. Europe Mebendazole Revenue by Type (2019-2024) & (US$ Million)
Table 109. Europe Mebendazole Revenue by Type (2025-2030) & (US$ Million)
Table 110. Europe Mebendazole Sales by Type (2019-2024) & (K Units)
Table 111. Europe Mebendazole Sales by Type (2025-2030) & (K Units)
Table 112. Europe Mebendazole Sales Price by Type (2019-2024) & (USD/Unit)
Table 113. Europe Mebendazole Sales Price by Type (2025-2030) & (USD/Unit)
Table 114. Europe Mebendazole Revenue by Application (2019-2024) & (US$ Million)
Table 115. Europe Mebendazole Revenue by Application (2025-2030) & (US$ Million)
Table 116. Europe Mebendazole Sales by Application (2019-2024) & (K Units)
Table 117. Europe Mebendazole Sales by Application (2025-2030) & (K Units)
Table 118. Europe Mebendazole Sales Price by Application (2019-2024) & (USD/Unit)
Table 119. Europe Mebendazole Sales Price by Application (2025-2030) & (USD/Unit)
Table 120. Europe Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 121. Europe Mebendazole Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 122. Europe Mebendazole Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 123. Europe Mebendazole Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 124. Europe Mebendazole Sales by Country (2019-2024) & (K Units)
Table 125. Europe Mebendazole Sales by Country (2025-2030) & (K Units)
Table 126. Europe Mebendazole Sales Price by Country (2019-2024) & (USD/Unit)
Table 127. Europe Mebendazole Sales Price by Country (2025-2030) & (USD/Unit)
Table 128. Germany Mebendazole Revenue (2019-2030) & (US$ Million)
Table 129. France Mebendazole Revenue (2019-2030) & (US$ Million)
Table 130. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 131. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 132. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 133. China Mebendazole Revenue by Type (2019-2024) & (US$ Million)
Table 134. China Mebendazole Revenue by Type (2025-2030) & (US$ Million)
Table 135. China Mebendazole Sales by Type (2019-2024) & (K Units)
Table 136. China Mebendazole Sales by Type (2025-2030) & (K Units)
Table 137. China Mebendazole Sales Price by Type (2019-2024) & (USD/Unit)
Table 138. China Mebendazole Sales Price by Type (2025-2030) & (USD/Unit)
Table 139. China Mebendazole Revenue by Application (2019-2024) & (US$ Million)
Table 140. China Mebendazole Revenue by Application (2025-2030) & (US$ Million)
Table 141. China Mebendazole Sales by Application (2019-2024) & (K Units)
Table 142. China Mebendazole Sales by Application (2025-2030) & (K Units)
Table 143. China Mebendazole Sales Price by Application (2019-2024) & (USD/Unit)
Table 144. China Mebendazole Sales Price by Application (2025-2030) & (USD/Unit)
Table 145. Asia Mebendazole Revenue by Type (2019-2024) & (US$ Million)
Table 146. Asia Mebendazole Revenue by Type (2025-2030) & (US$ Million)
Table 147. Asia Mebendazole Sales by Type (2019-2024) & (K Units)
Table 148. Asia Mebendazole Sales by Type (2025-2030) & (K Units)
Table 149. Asia Mebendazole Sales Price by Type (2019-2024) & (USD/Unit)
Table 150. Asia Mebendazole Sales Price by Type (2025-2030) & (USD/Unit)
Table 151. Asia Mebendazole Revenue by Application (2019-2024) & (US$ Million)
Table 152. Asia Mebendazole Revenue by Application (2025-2030) & (US$ Million)
Table 153. Asia Mebendazole Sales by Application (2019-2024) & (K Units)
Table 154. Asia Mebendazole Sales by Application (2025-2030) & (K Units)
Table 155. Asia Mebendazole Sales Price by Application (2019-2024) & (USD/Unit)
Table 156. Asia Mebendazole Sales Price by Application (2025-2030) & (USD/Unit)
Table 157. Asia Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 158. Asia Mebendazole Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 159. Asia Mebendazole Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 160. Asia Mebendazole Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 161. Asia Mebendazole Sales by Country (2019-2024) & (K Units)
Table 162. Asia Mebendazole Sales by Country (2025-2030) & (K Units)
Table 163. Asia Mebendazole Sales Price by Country (2019-2024) & (USD/Unit)
Table 164. Asia Mebendazole Sales Price by Country (2025-2030) & (USD/Unit)
Table 165. Japan Mebendazole Revenue (2019-2030) & (US$ Million)
Table 166. South Korea Mebendazole Revenue (2019-2030) & (US$ Million)
Table 167. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 168. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 169. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 170. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 171. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 172. Mebendazole Revenue (2019-2030) & (US$ Million)
Table 173. MEALA Mebendazole Revenue by Type (2019-2024) & (US$ Million)
Table 174. MEALA Mebendazole Revenue by Type (2025-2030) & (US$ Million)
Table 175. MEALA Mebendazole Sales by Type (2019-2024) & (K Units)
Table 176. MEALA Mebendazole Sales by Type (2025-2030) & (K Units)
Table 177. MEALA Mebendazole Sales Price by Type (2019-2024) & (USD/Unit)
Table 178. MEALA Mebendazole Sales Price by Type (2025-2030) & (USD/Unit)
Table 179. MEALA Mebendazole Revenue by Application (2019-2024) & (US$ Million)
Table 180. MEALA Mebendazole Revenue by Application (2025-2030) & (US$ Million)
Table 181. MEALA Mebendazole Sales by Application (2019-2024) & (K Units)
Table 182. MEALA Mebendazole Sales by Application (2025-2030) & (K Units)
Table 183. MEALA Mebendazole Sales Price by Application (2019-2024) & (USD/Unit)
Table 184. MEALA Mebendazole Sales Price by Application (2025-2030) & (USD/Unit)
Table 185. MEALA Mebendazole Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 186. MEALA Mebendazole Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 187. MEALA Mebendazole Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 188. MEALA Mebendazole Sales by Country (2019 VS 2023 VS 2030) & (K Units)
Table 189. MEALA Mebendazole Sales by Country (2019-2024) & (K Units)
Table 190. MEALA Mebendazole Sales by Country (2025-2030) & (K Units)
Table 191. MEALA Mebendazole Sales Price by Country (2019-2024) & (USD/Unit)
Table 192. MEALA Mebendazole Sales Price by Country (2025-2030) & (USD/Unit)
Table 193. Mexico Mebendazole Revenue (2019-2030) & (US$ Million)
Table 194. Brazil Mebendazole Revenue (2019-2030) & (US$ Million)
Table 195. Israel Mebendazole Revenue (2019-2030) & (US$ Million)
Table 196. Argentina Mebendazole Revenue (2019-2030) & (US$ Million)
Table 197. Colombia Mebendazole Revenue (2019-2030) & (US$ Million)
Table 198. Turkey Mebendazole Revenue (2019-2030) & (US$ Million)
Table 199. Saudi Arabia Mebendazole Revenue (2019-2030) & (US$ Million)
Table 200. UAE Mebendazole Revenue (2019-2030) & (US$ Million)
Table 201. Key Raw Materials
Table 202. Raw Materials Key Suppliers
Table 203. Mebendazole Distributors List
Table 204. Mebendazole Customers List
Table 205. Research Programs/Design for This Report
Table 206. Authors List of This Report
Table 207. Secondary Sources
Table 208. Primary Sources
List of Figures
Figure 1. Mebendazole Product Picture
Figure 2. Global Mebendazole Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Mebendazole Market Size Share 2019 VS 2023 VS 2030
Figure 4. Tablet Picture
Figure 5. Oral Suspension Picture
Figure 6. Global Mebendazole Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Mebendazole Market Size Share 2019 VS 2023 VS 2030
Figure 8. Below 2 Years Old Picture
Figure 9. Above 2 Years Old Picture
Figure 10. Global Mebendazole Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Mebendazole Revenue (2019-2030) & (US$ Million)
Figure 12. Global Mebendazole Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Mebendazole Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Mebendazole Revenue Market Share by Region (2019-2030)
Figure 15. Global Mebendazole Sales (2019-2030) & (K Units)
Figure 16. Global Mebendazole Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 17. Global Mebendazole Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Mebendazole Sales YoY (2019-2030) & (K Units)
Figure 19. Europe Mebendazole Sales YoY (2019-2030) & (K Units)
Figure 20. China Mebendazole Sales YoY (2019-2030) & (K Units)
Figure 21. Asia (Excluding China) Mebendazole Sales YoY (2019-2030) & (K Units)
Figure 22. Middle East, Africa and Latin America (Excluding China) Mebendazole Sales YoY (2019-2030) & (K Units)
Figure 23. Global Mebendazole Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Mebendazole Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Mebendazole Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Mebendazole Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Mebendazole Revenue Market Share by Type (2019-2030)
Figure 29. Global Mebendazole Sales by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 30. Global Mebendazole Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Mebendazole Sales Market Share by Type (2019-2030)
Figure 32. Global Mebendazole Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Mebendazole Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Mebendazole Revenue Market Share by Application (2019-2030)
Figure 35. Global Mebendazole Sales by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 36. Global Mebendazole Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Mebendazole Sales Market Share by Application (2019-2030)
Figure 38. North America Mebendazole Revenue Share by Type (2019-2030)
Figure 39. North America Mebendazole Sales Share by Type (2019-2030)
Figure 40. North America Mebendazole Revenue Share by Application (2019-2030)
Figure 41. North America Mebendazole Sales Share by Application (2019-2030)
Figure 42. North America Mebendazole Revenue Share by Country (2019-2030)
Figure 43. North America Mebendazole Sales Share by Country (2019-2030)
Figure 44. Europe Mebendazole Revenue Share by Type (2019-2030)
Figure 45. Europe Mebendazole Sales Share by Type (2019-2030)
Figure 46. Europe Mebendazole Revenue Share by Application (2019-2030)
Figure 47. Europe Mebendazole Sales Share by Application (2019-2030)
Figure 48. Europe Mebendazole Revenue Share by Country (2019-2030)
Figure 49. Europe Mebendazole Sales Share by Country (2019-2030)
Figure 50. China Mebendazole Revenue Share by Type (2019-2030)
Figure 51. China Mebendazole Sales Share by Type (2019-2030)
Figure 52. China Mebendazole Revenue Share by Application (2019-2030)
Figure 53. China Mebendazole Sales Share by Application (2019-2030)
Figure 54. Asia Mebendazole Revenue Share by Type (2019-2030)
Figure 55. Asia Mebendazole Sales Share by Type (2019-2030)
Figure 56. Asia Mebendazole Revenue Share by Application (2019-2030)
Figure 57. Asia Mebendazole Sales Share by Application (2019-2030)
Figure 58. Asia Mebendazole Revenue Share by Country (2019-2030)
Figure 59. Asia Mebendazole Sales Share by Country (2019-2030)
Figure 60. MEALA Mebendazole Revenue Share by Type (2019-2030)
Figure 61. MEALA Mebendazole Sales Share by Type (2019-2030)
Figure 62. MEALA Mebendazole Revenue Share by Application (2019-2030)
Figure 63. MEALA Mebendazole Sales Share by Application (2019-2030)
Figure 64. MEALA Mebendazole Revenue Share by Country (2019-2030)
Figure 65. MEALA Mebendazole Sales Share by Country (2019-2030)
Figure 66. Mebendazole Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Mebendazole Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
